BHC
Bausch Health Companies Inc.
$5.75
+0.35%
2026-05-08
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Key Fundamentals
P/E Ratio
14.30
Forward P/E
1.39
EPS (TTM)
$-3.24
ROE
436.4%
Revenue Growth (YoY)
11.7%
Profit Margin
-11.5%
Debt/Equity
5591.25
Beta
0.42
Market Cap
$2.11B
Avg Volume (10D)
2.4M
Recent Breakout Signals
No recent breakout signals detected for BHC.
Recent Price Range (60 Days)
60D High
$6.33
60D Low
$4.93
Avg Volume
1.6M
Latest Close
$5.75
Get breakout alerts for BHC
Sign up for Breakout Scanner to receive daily notifications when BHC triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Bausch Health Companies Inc. (BHC) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors BHC daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. BHC operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.